Dr David Alexander Leonard Newcombe
BA, BA (Hons), PhD
I have had over twenty year's experience working in the addiction sector in New Zealand and Australia. I completed my undergraduate and postgraduate degrees in psychology and neuroscience at Flinders University and doctoral studies in psychopharmacology at Adelaide University in South Australia. Previously I worked at the WHO Collaborating Centre for Research in the Treatment of Drug and Alcohol Problems at University of Adelaide where I was involved with many large multinational multi site studes (including the validation of the Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST)). In addition to my teaching responsibilities I am an Associate Director of the Centre for Addiction Research at University of Auckland.
My current research interests include: Evaluating screening and brief interventions for problematic drug use in different contexts, the use of pharmacotherapy for treating addiction disorders, the cognitive effects of drugs of abuse through the lifespan; and the impact of co-existing problems (including prescription medication use) on well-being, and alcohol and drug use in older adults.
Research | Current
- Screening and brief interventions for problematic alcohol and drug use
- Clinical pharmacology of pharmacotherapies used for the treatment of dependence
- Cognitive effects of drugs of abuse
- The impact of co-existing problems (including prescription medication use) on well-being.
- Alcohol and drug use in older adults
Teaching | Current
I coordinate the following courses:
POPLRAC 765: Co-existing Disorders - Theory and Principles
POPLHLTH 738: Biology of Addiction
POPLHLTH 773: Pharmacotherapeutic Responses to Addiction
POPLPRAC 708: Assessment and Intervention with Addiction
POPLHLTH 212: Biobehavioural Aspects of Drug Use
Currently supervising postgraduate students undertaking the following research:
- Development, reliability and validity of a questionnaire to screen for problematic internet use
- Substance use and health utilisation in older adults with addiction
- E-cigarettes: Acceptability and feasibility for smoking cessation and harm reduction in alcohol and other drug (AOD) treatment
- The experiences and outcomes of those receiving treatment for opioid dependence who have initiated their opioid use through legitimate pathways
2019. Prime Minister's Chief Scientific Advisor Legalisation of Cannabis Expert Panel
2019. Butland Award for Leadership in Teaching
2017. US National Institute for Drug Abuse, Distinguished International Scientist Collaboration Award (DISCA)
2016. Supreme Winner - National Workforce Innovation Award 2014 (Matua Raki).
1998. Australian Post Graduate Research Award for doctoral studies
Head of Section, Social and Community Health, Social and Community Health
Academic Director, Alcohol and Drug Studies Programmes.
Associate Director, Centre for Addiction Research http://www.fmhs.auckland.ac.nz/cfar
Areas of expertise
Screening and brief intervention for risky drug use
The cognitive effects of drugs of abuse
New Zealand Representative, Australasian Professional Society on Alcohol and Other Drugs Council
Member, Australasian Professional Society on Alcohol and Other Drugs
Chair, Training Providers Network
Selected publications and creative works (Research Outputs)
- Jeong, S. H., Sheridan, J., Bullen, C., Newcombe, D., Walker, N., & Tingle, M. (2019). Ascending single dose pharmacokinetics of cytisine in healthy adult smokers. Xenobiotica; the fate of foreign compounds in biological systems, 49 (11), 1332-1337. 10.1080/00498254.2018.1557760
Other University of Auckland co-authors: Soo Hee Jeong, Janie Sheridan, Malcolm Tingle, Chris Bullen, Natalie Walker
- Newcombe, D. A. L., Taufa, S., Tanielu, H., & Nosa, V. (2019). Substance misuse stories among Pacific peoples in New Zealand. Kōtuitui : New Zealand Journal of Social Sciences Online, 14 (1), 68-79. 10.1080/1177083X.2018.1528991
Other University of Auckland co-authors: Vili Nosa
- Schenk, S., & Newcombe, D. (2018). Methylenedioxymethamphetamine (MDMA) in Psychiatry: Pros, Cons, and Suggestions. Journal of clinical psychopharmacology, 38 (6), 632-638. 10.1097/jcp.0000000000000962
- Newcombe, D., Knaebe, B., Malloy, R., Peacock, A., & Bruno, R. (2018). ARE CONSUMERS OF ALCOHOL AND CAFFEINATED ENERGY DRINKS RISK TAKERS?. DRUG AND ALCOHOL REVIEW. (pp. 1).
- Ali, R., & Newcombe, D. (2018). WORKSHOP: SCALING UP SCREENING, BRIEF INTERVENTION AND REFERRAL TO TREATMENT IN PRIMARY HEALTH CARE: HOW THE ASSIST CAN HELP YOU. DRUG AND ALCOHOL REVIEW. (pp. 1).
- Walker, N., McCormack, J., Mathers, K., Newcombe, D., Jones, R., Parag, V., ... Dulin, P. (2018). ACCEPTABILITY AND UTILITY OF THE 'STEPAWAY' APP IN A NEW ZEALAND CONTEXT: FEEDBACK FROM END-USERS AND STAKEHOLDERS. DRUG AND ALCOHOL REVIEW. (pp. 1).
Other University of Auckland co-authors: Jessica McCormack
- Sheridan, J., Bespalova, P., Chong, W., Lee, J. S., Romic, S., Ting, E., & Newcombe, D. (7/7/2018). Substance misuse and addictions: What do schools of pharmacy teach?. Poster presented at Life Long Learning in Pharmacy (LLLP) Conference, Brisbane, Australia. Pharmacy Education, 2018; 18 (1) 1 - 54. Related URL.
Other University of Auckland co-authors: Janie Sheridan
- Newcombe, D., Artigiani, E., & Wish, E. (8/6/2018). Exploring global drug early warning systems: An international collaboration. Poster presented at 2018 National Institute on Drug Abuse (NIDA) International Forum: Building International Collaborative Research on Drug Abuse, San Diego, California, USA. Related URL.